21 CFR 526.465
§ 526.465 Cloxacillin sodium.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 526.465, § 526.465 Cloxacillin sodium, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87666
- Permanent ID
ys:prov:87666@1- SHA-256
698928b70997f148f751f633a8a344548ce49a86403e4ff62831ecb08ae48dab
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each single-dose, 10-milliliter syringe contains cloxacillin sodium equivalent to 200 milligrams (mg) cloxacillin.
(b) Sponsor. See No. 000061 in § 510.600(c) of this chapter.
(c) Related tolerances. See § 556.165 of this chapter.
(d) Conditions of use in lactating cows—(1) Amount. Infuse the contents of one syringe (equivalent to 200 mg cloxacillin) into each infected quarter. Treatment should be repeated at 12-hour intervals for a total of 3 doses.
(2) Indications for use. For the treatment of mastitis in lactating cows due to Streptococcus agalactiae and Staphylococcus aureus, nonpenicillinase-producing strains.
(3) Limitations. Milk taken from treated animals within 48 hours (4 milkings) after the latest treatment should not be used for food. Treated animals should not be slaughtered for food within 10 days after the latest treatment. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.